Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program

Uriel R. Felsen, Dawn A. Fishbein, Alain H. Litwin

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Patients with chronic hepatitis C virus (HCV) are at increased risk for complications of liver disease if they become infected with the hepatitis A (HAV) or hepatitis B (HBV) viruses. The authors examined the rates of testing for HAV, HBV, and HCV, as well as rates of vaccination against HAV and HBV in patients with chronic HCV in a random sample (N = 207) of medical records of patients enrolled in a methadone maintenance program. Almost all patients reviewed were tested for HAV, HBV, and HCV. Of the 111 patients with chronic HCV, 53 (48.6%) and 68 (63%) lacked immunity to HAV and HBV, respectively. Of those lacking immunity, 29 (54.7%) and 2 (2.9%) were vaccinated for HAV and HBV, respectively. Despite high rates of testing for HAV, HBV, and HCV at a methadone maintenance program, approximately half of those with chronic HCV eligible for the HAV vaccine received it, and few of those eligible for HBV vaccine received it.

Original languageEnglish (US)
Pages (from-to)461-465
Number of pages5
JournalJournal of Addictive Diseases
Volume29
Issue number4
DOIs
StatePublished - Oct 2010

Keywords

  • Hepatitis
  • methadone
  • vaccination

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program'. Together they form a unique fingerprint.

  • Cite this